Certain H Shares of Lepu Biopharma Co., Ltd. are subject to a Lock-Up Agreement Ending on 23-FEB-2023. These H Shares will be under lockup for 366 days starting from 22-FEB-2022 to 23-FEB-2023.

Details:
The Controlling Shareholder has undertaken to each of the Company, the Joint Global Coordinators, the Joint Bookrunners, the Hong Kong Underwriters and the Joint Sponsors that, except pursuant to the Global Offering (including pursuant to the Over-allotment Option) without the prior written consent of the Joint Sponsors and the Joint Global Coordinators (for themselves and on behalf of the Hong Kong Underwriters) and unless in compliance with the requirements of the Listing Rules at any time during the First Six-Month Period will not sell, offer to sell, contract or agree to sell, mortgage, charge, pldege, hypothecate, lend, grant or sell any option, warrant, contract or right to purchase, grant or purchase any option, warrant, contract or right to sell, or otherwise transfer or dispose of or create an encumbrance over, or agree to transfer or dispose of or create an encumbrance over, either directly or indirectly, conditionally or unconditionally, any Shares or other securities of the Company or any interest in any of the foregoing (including any securities convertible into or exchangeable or exercisable for, or that represent the right to receive, or any warrants or other rights to purchase, any Shares) (the “Locked-up Securities”) or deposit any Shares or other securities of the Company with a depositary in connection with the issue of depositary receipts.

In each case, whether any such transaction described in above is to be settled by delivery of Shares or other securities of the Company, or in cash or otherwise (whether or not the issue of such Shares or other securities will be completed within the First Six-Month Period or the Second Six Month Period). Until the expiry of the Second Six-Month Period, in the event that he or the relevant registered holder(s) enters into any such transactions specified in paragraphs (a), (b) or (c) above or offers to or agrees to or announces any intention to effect any such transactions, he will take all reasonable steps to ensure that it will not create a disorderly or false market in the securities of the Company; and at any time during the First Six Month Period and the Second Six Month Period, he will (a) if and when he or it pledges or charges any Shares or other securities of the Company beneficially owned by him, immediately inform the Company and the Joint Global Coordinators in writing of such pledge or charge together with the number of Shares or other securities of the Company so pledged or charged; and (b) if and when he receives indications, either verbal or written, from any pledgee or chargee that any of the pledged or charged Shares or other securities of the Company will be disposed of, immediately inform the Company and the Joint Global Coordinators in writing of such indications.